140 related articles for article (PubMed ID: 8137859)
1. Effect of alpha-interferon alone and combined with other antineoplastic agents on renal cell carcinoma determined by the tetrazolium microculture assay.
Homma Y; Aso Y
Eur Urol; 1994; 25(2):164-70. PubMed ID: 8137859
[TBL] [Abstract][Full Text] [Related]
2. Interferon treatment of renal cell carcinoma. Current status and future prospects.
Krown SE
Cancer; 1987 Feb; 59(3 Suppl):647-51. PubMed ID: 10822464
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
Baisch H; Otto U; Klöppel G
Cancer Res; 1990 Oct; 50(19):6389-95. PubMed ID: 2400997
[TBL] [Abstract][Full Text] [Related]
5. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
Ohmura K; Tsukamoto T
Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
[TBL] [Abstract][Full Text] [Related]
6. Biochemical modulation of 5-fluorouracil with murine interferon-alpha/beta against murine renal cell carcinoma.
Marumo K; Oya M; Murai M
Int J Urol; 1997 Mar; 4(2):163-8. PubMed ID: 9179690
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
[TBL] [Abstract][Full Text] [Related]
8. Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Küpeli S; Beksac M; Küpeli B; Baltaci S; Süzer O
Int Urol Nephrol; 1997; 29(4):421-6. PubMed ID: 9405998
[TBL] [Abstract][Full Text] [Related]
9. Role of interferons in the therapy of metastatic renal cell carcinoma.
Quesada JR
Urology; 1989 Oct; 34(4 Suppl):80-3; discussion 87-96. PubMed ID: 2678687
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2a.
de Riese W; Allhoff E; Stief CG; Lenis G; Schlick R; Liedke S; Anton P; Jonas U
Urol Res; 1991; 19(2):87-90. PubMed ID: 1906658
[TBL] [Abstract][Full Text] [Related]
11. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
14. [Combined effects of alpha-interferon and anticancer drugs against renal cell carcinoma].
Sasagawa T
Hinyokika Kiyo; 1990 Dec; 36(12):1397-401. PubMed ID: 1706135
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.
Beniers AJ; van Moorselaar RJ; Peelen WP; Debruyne FM; Schalken JA
Urol Res; 1991; 19(2):91-8. PubMed ID: 1906659
[TBL] [Abstract][Full Text] [Related]
16. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
Maurer-Schultze B; Bassukas ID; Hofmockel G
Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.
Sella A; Logothetis CJ; Fitz K; Dexeus FH; Amato R; Kilbourn R; Wallace S
J Urol; 1992 Mar; 147(3):573-7. PubMed ID: 1538431
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
[TBL] [Abstract][Full Text] [Related]
19. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
20. Effect of alpha- and gamma-interferon and tumor necrosis factor on colony formation of two human renal tumor xenografts in vitro.
Beniers AJ; Peelen WP; Hendriks BT; Schalken JA; Debruyne FM
Semin Surg Oncol; 1988; 4(3):195-8. PubMed ID: 3142009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]